Efraín I. Flores-Hernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Efraín I. Flores-Hernández has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Maria Guadalupe Zavala-Cerna
Unidad Academica Ciencias de la Salud, Universidad Autónoma de Guadalajara, Zapopan 45129, Jalisco, Mexico
2 shared publications - Alma L. Guzmán-Gurrola
High Specialty Geriatric Care Unit, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara 44200, Mexico
1 shared publication - Arnulfo Hernán Nava-Zavala
Unidad de Investigacion Epidemiologica y en Servicios de Salud, Centro Medico Nacional de Occidente Organo de Operación Administrativa Desconcentrada Jalisco, Instituto Mexicano del Seguro Social, Guadalajara 44329, Jalisco, Mexico
1 shared publication - Erika A. Martínez García
Departamento de Biología Molecular y Genómica, Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico
1 shared publication - Jonathan Samuel Chavez Iñiguez
Nephrology Department, Hospital Civil de Guadalajara Fray Antonio Alcalde
1 shared publication - José A. Novoa-Burquez
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Gobierno y Municipios del Estado de Baja California, Tijuana 22520, Mexico
1 shared publication
Latest Publications
- Open Access
- 26 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2182
A Preliminary Exploratory Study Based on LC–MS/MS and LFQ for Candidate Protein Biomarkers in Peripheral Blood from Rheumatoid Arthritis
Objective: Detangling the rheumatoid arthritis (RA) proteomic profile is of interest to improve diagnosis, RA subclassifications, and targeted treatment. We aimed at identifying serum proteins as candidate biomarkers for RA. Methods: This case-control study included participants with RA and healthy controls (HCs) paired by gender; clinical information and proteomic profiles were analyzed for the identification of candidate protein biomarkers. A statistical analysis included logistic regression and ROC curves for AUC measurement. Results: Following the screening of 176 patients, 25 RA and 25 HC patients were included in this study. The average age was 51 ± 12 years, and 90% were females. Notably, we identified five serum protein candidate biomarkers with differential expression when comparing RA to HC, consisting of testis-expressed protein 13B (p = 6.31 × 10−4), keratin type II cytoskeletal 79 (p = 1.317 × 10−4), 60 kDa heat shock protein (p = 7.594 × 10−4), pseudo uridylate synthase 7 homolog (p = 8.332 × 10−3), and SUN domain-containing protein 3 (p = 1.883 × 10−7). The first four proteins were predominantly observed in patients with RA, while the last was predominantly identified in the HCs. Conclusions: A distinctive serum candidate biomarker profile consistent in five proteins was identified for RA, suggesting a unique stress-related, inflammatory signature. Collectively, the profile exhibits potential, but our findings must be validated in larger cohort studies, preferably in the context of undifferentiated arthritis before a definitive model for diagnosis is established.
- 26 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2182
Open AccessA Preliminary Exploratory Study Based on LC–MS/MS and LFQ for Candidate Protein Biomarkers in Peripheral Blood from Rheumatoid Arthritis
Objective: Detangling the rheumatoid arthritis (RA) proteomic profile is of interest to improve diagnosis, RA subclassifications, and targeted treatment. We aimed at identifying serum proteins as candidate biomarkers for RA. Methods: This case-control study included participants with RA and healthy controls (HCs) paired by gender; clinical information and proteomic profiles were analyzed for the identification of candidate protein biomarkers. A statistical analysis included logistic regression and ROC curves for AUC measurement. Results: Following the screening of 176 patients, 25 RA and 25 HC patients were included in this study. The average age was 51 ± 12 years, and 90% were females. Notably, we identified five serum protein candidate biomarkers with differential expression when comparing RA to HC, consisting of testis-expressed protein 13B (p = 6.31 × 10−4), keratin type II cytoskeletal 79 (p = 1.317 × 10−4), 60 kDa heat shock protein (p = 7.594 × 10−4), pseudo uridylate synthase 7 homolog (p = 8.332 × 10−3), and SUN domain-containing protein 3 (p = 1.883 × 10−7). The first four proteins were predominantly observed in patients with RA, while the last was predominantly identified in the HCs. Conclusions: A distinctive serum candidate biomarker profile consistent in five proteins was identified for RA, suggesting a unique stress-related, inflammatory signature. Collectively, the profile exhibits potential, but our findings must be validated in larger cohort studies, preferably in the context of undifferentiated arthritis before a definitive model for diagnosis is established.
- Open Access
- 5 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1994
Sex-Specific Differences in Nutritional Status and Olfaction in Association with Cognitive Impairment Amongst Older Adults with Long COVID Syndrome
Background/Objectives: Long COVID has emerged as a significant public health concern, characterized by persistent symptoms following SARS-CoV-2 infection. Cognitive impairment is a common sequela, particularly among older adults (OAs). Although olfactory dysfunction and malnutrition have been previously associated with cognitive decline, it remains elusive to what extent sex-specific variations in these and additional factors will be pivotal to guiding targeted interventions in a sex-specific manner. To fill this gap in knowledge, we undertook a study with the purpose of investigating the contribution of sex-specific risk factors to the development of cognitive impairment (CI) in a cohort of OAs hospitalized with long COVID. Methods: We undertook a cross-sectional study among OAs hospitalized at a geriatric care unit. Olfactory function was assessed using the Sniffin’ Stick Test. Cognitive impairment was evaluated by the Mini-Mental State Examination, and nutritional status was assessed with the Mini Nutritional Assessment (MNA). Statistical analyses included linear regression. Results: A total of 45 patients with long COVID were included, of whom 51% were female. The prevalence of CI was lower in men compared to women. In the single variable analysis, nutritional factors were associated with CI only in women; importantly, the loss of olfactory function was associated with CI in the whole group and to CI in women after multivariate analysis. Conclusions: Olfactory dysfunction is a potential biomarker for cognitive impairment in OAs with long COVID in a sex-specific manner. In our study nutritional status and probable obesity could be additional factors associated with CI; nevertheless, this was not confirmed in our multivariate analysis; therefore, this hypothesis would need to be tested in larger studies.
- 5 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1994
Open AccessSex-Specific Differences in Nutritional Status and Olfaction in Association with Cognitive Impairment Amongst Older Adults with Long COVID Syndrome
Background/Objectives: Long COVID has emerged as a significant public health concern, characterized by persistent symptoms following SARS-CoV-2 infection. Cognitive impairment is a common sequela, particularly among older adults (OAs). Although olfactory dysfunction and malnutrition have been previously associated with cognitive decline, it remains elusive to what extent sex-specific variations in these and additional factors will be pivotal to guiding targeted interventions in a sex-specific manner. To fill this gap in knowledge, we undertook a study with the purpose of investigating the contribution of sex-specific risk factors to the development of cognitive impairment (CI) in a cohort of OAs hospitalized with long COVID. Methods: We undertook a cross-sectional study among OAs hospitalized at a geriatric care unit. Olfactory function was assessed using the Sniffin’ Stick Test. Cognitive impairment was evaluated by the Mini-Mental State Examination, and nutritional status was assessed with the Mini Nutritional Assessment (MNA). Statistical analyses included linear regression. Results: A total of 45 patients with long COVID were included, of whom 51% were female. The prevalence of CI was lower in men compared to women. In the single variable analysis, nutritional factors were associated with CI only in women; importantly, the loss of olfactory function was associated with CI in the whole group and to CI in women after multivariate analysis. Conclusions: Olfactory dysfunction is a potential biomarker for cognitive impairment in OAs with long COVID in a sex-specific manner. In our study nutritional status and probable obesity could be additional factors associated with CI; nevertheless, this was not confirmed in our multivariate analysis; therefore, this hypothesis would need to be tested in larger studies.